✦ LIBER ✦

BOLERO-2: Everolimus in combination with exemestane in the treatment of postmenopausal women with estrogen receptor-positive ADVANCED breast cancer refractory to letrozole or anastrozole

✍ Scribed by Mario Campone; Martine Piccart; Kathleen I. Pritchard; Cindy Xu; Michael Gnant; Patrick Neven; Barbara Pistilli; Mikhail Shtivelband; Louise Provencher; Norikazu Masuda; Mona El-Hashimy; Luc Vittori; Tarek Sahmoud; Jose Baselga; Gabriel N. Hortobagyi

Book ID: 113507446
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 46 KB
Volume: 20
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2011.08.052

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Everolimus in Combination with Exemestan

Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO-2 Phase III Trial

✍ J. Baselqa; M. Campone; T. Sahmoud; M. Piccart; H. Burris; H. Rugo; S. Noguchi; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Pharmacoeconomic analysis of adjuvant th

Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer

✍ Juan Miguel Gil; Carlos Rubio-Terrés; Almudena del Castillo; Paloma González; Fe 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 827 KB

253 Everolimus (EVE) for Postmenopausal

253 Everolimus (EVE) for Postmenopausal Women with Advanced Breast Cancer (ABC) Refractory to Letrozole or Anastrozole: Long-term Efficacy and Safety Results of the BOLERO-2 Trial

✍ H. Rugo; K.I. Pritchard; M. Gnant; S. Noguchi; M. Piccart; G.N. Hortobagyi; H.A. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

The BOLERO-2 trial: the addition of ever

The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer

✍ Beaver, Julia A; Park, Ben H 📂 Article 📅 2012 🏛 Future Medicine 🌐 English ⚖ 804 KB

12 Everolimus Added to Exemestane Reduce

12 Everolimus Added to Exemestane Reduced Bone Markers in Postmenopausal Women with Advanced Breast Cancer (ABC): the BOLERO-2 Trial

✍ M. Gnant; G.N. Hortobagyi; H. Rugo; H.A. Burris; S. Noguchi; K.I. Pritchard; J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Everolimus in Combination with Exemestan

Everolimus in Combination with Exemestane: A Review of its Use in the Treatment of Patients with Postmenopausal Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

✍ Sohita Dhillon 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 426 KB